Positive interim results from Phase I/II multiple myeloma cancer vaccine trial

被引：0
|
作者：
Riedmann, Eva M.
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2012年 / 8卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：696 / 697
页数：2
相关论文
共 50 条
  • [31] Cabozantinib in high grade neuroendocrine neoplasms - Interim results from a Phase II trial
    Trikalinos, N.
    Pedersen, K.
    Tan, B.
    Amin, M.
    Rama, S.
    Park, H.
    Lim, K. H.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 239 - 239
  • [32] Phase I/II trial results reported for Neovastat in lung cancer
    不详
    DRUG NEWS & PERSPECTIVES, 1998, 11 (01) : 57 - 57
  • [33] Avant reports positive results from Phase II trial of CholeraGarde®
    不详
    EXPERT REVIEW OF VACCINES, 2005, 4 (04) : 451 - 451
  • [34] Phase I/II Study of Panobinostat and Carfilzomib in Patients (pts) with Relapsed or Refractory Multiple Myeloma (MM), Interim Phase I Safety Analysis
    Berdeja, Jesus G.
    Hart, Lowell
    Lamar, Ruth
    Murphy, Patrick
    Morgan, Susan
    Flinn, Ian W.
    BLOOD, 2012, 120 (21)
  • [35] Combination of bortezomib, melphalan, prednisone and thalidomide (VMPT) for relapsed multiple myeloma: Results of a phase I/II clinical trial.
    Palumbo, Antonio
    Ambrosini, Maria Teresa
    Benevolo, Giulia
    Pregno, Patrizia
    Pescosta, Norbert
    Callea, Vincenzo
    Cangialosi, Clotilde
    Caravita, Tommaso
    Morabito, Fortunato
    Musto, Legrino
    Bringhen, Sara
    Gay, Francesca
    Rus, Cecilia
    Boccadoro, Mario
    BLOOD, 2006, 108 (11) : 125A - 125A
  • [36] Bortezomib, low dose intravenous melphalan and dexamethasone for patients with relapsed multiple myeloma: results of a phase I/II clinical trial
    Popat, R.
    Williams, C.
    Cook, M.
    Craddock, C.
    Basu, S.
    Singeri, C.
    Gurnbleton, T.
    Foot, N.
    Oakervee, H.
    Cavenagh, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 60 - 61
  • [37] Positive interim Phase II results of PRO 140 for HIV treatment
    不详
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (06) : 783 - 783
  • [38] Cytomegalovirus vaccine: phase II clinical trial results
    Rieder, F.
    Steininger, C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 95 - 102
  • [39] Human Neural Stem Cell Transplantation in Chronic SCI: Interim Results of a Phase I/II Trial
    Guzman, Raphael
    Schubert, Martin
    Keller-Lang, Dagmar
    Huhn, Stephen L.
    Curt, Armin
    NEUROSURGERY, 2013, 60 : 185 - 185
  • [40] Lenalidomide, Adriamycin and Dexamethason (RAD) in Relapsed and Refractory Multiple Myeloma: Final Results from a Phase I/II Trial of "Deutsche Studiengruppe Multiples Myelom".
    Gerecke, Christian
    Knop, Stefan
    Topp, Max S.
    Liebisch, Peter
    Vollmuth, Christina
    Platzbecker, Uwe
    Maeder, Uwe
    Einsele, Hermann
    Bargou, Ralf C.
    BLOOD, 2008, 112 (11) : 961 - 961
12345